MCL-R2-Elderly (Lysa) (FL)

MCL-R2-Elderly (Lysa) (FL)

Efficacy of Alternating Immunochemotherapy Consisting of R-CHOP + R-HAD vs R-CHOP Alone, Followed by Maintenance Therapy Consisting of Additional Lenalidomide + Rituximab vs Rituximab Alone for Older Patients With Mantle Cell Lymphoma (MCL)


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites


Link